ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
港股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
高瓴概念
524.566
+3.669
0.70%
手动刷新
涨家数:
39
跌家数:
13
平家数:
3
市盈率:
- -
高:
524.679
开:
520.909
低:
517.717
收:
520.897
成交量:
2.51亿
成交额:
51.99亿
市值:
3.12万亿
流通市值:
2.35万亿
数据加载中...
总览
新闻
信达生物与圣因生物共同宣布IBI3016(AGT siRNA)I期临床研究结果于2025年AHA大会现场报告
美通社
·
4小时前
医保卡变“购物卡”?央视曝光“套”刷医保卡黑链条
央视
·
4小时前
深耕骨科 50 年,CeramTec凭什么成为强生、威高等巨头的依赖?
医工加油站
·
10小时前
BD神话带不动创新药了?
药闻社
·
昨天
国科恒泰:医疗器械第三方制造相关业务尚处于前期研究探索阶段
第一财经
·
昨天
【国投证券 | 医药】医药板块25Q3季报总结:创新出海率先回暖,其他细分静待改善
国投证券医药研究
·
昨天
【国投证券 | 医药】新药周观点:25Q3泽布替尼美国市场份额首次超越伊布替尼
国投证券医药研究
·
昨天
全国社保基金理事会原副理事长王忠民:低息差时代的资产管理核心就是向风险要收益、向风险要资产配置
每日经济新闻
·
昨天
美团在深圳启动“迎赛事•团行动” 助力城市文商旅体融合发展
滚动播报
·
昨天
兴证策略:“以我为主” 两条思路布局明年景气预期
兴业证券
·
昨天
借力进博舞台,联众医疗获SGS数据资产管理认证,推动医疗行业标准化破局
上观新闻
·
昨天
泰它西普治疗IGA肾病的优异疗效和安全性早已显露在销售收入里
新浪财经
·
昨天
快递迎来“小时达”时代!你的“身边仓”接单了
北京青年报官网
·
昨天
只拼价格不够!GLP-1减肥针“双十一”爆发式增长,京东健康在下一盘生态大棋
每日经济新闻
·
昨天
和铂医药-B于11月7日斥资497.15万港元回购40万股
新浪港股
·
昨天
归创通桥于11月7日斥资117.2万港元回购5万股
新浪港股
·
昨天
小小儿童餐 吃出“大蛋糕” 万亿市场规模引来众多知名餐饮企业布局
深圳商报
·
昨天
医药生物行业周报:流感高发 关注相关投资机会
开源证券
·
昨天
聚焦进博会|进口人工心脏、三尖瓣加速入华 心血管医疗器械赛道活跃
第一财经
·
11/08
(第八届进博会)民企话进博会:架起全球商品与中国消费者“双向奔赴”通道
中国新闻网
·
11/08
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK1583/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"高瓴概念","latestPrice":524.5661,"timestamp":1762747199373,"preClose":520.89703,"halted":0,"volume":250670138,"delay":0,"changeRate":0.007044,"floatShares":0,"shares":0,"eps":0,"marketStatus":"午间休市","change":3.669067,"latestTime":"11-10 12:00:00","open":520.9091,"high":524.6792,"low":517.7165,"amount":5199208711,"amplitude":0.013367,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1762750800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1762738200000,1762747200000],[1762750800000,1762761600000]],"pbRate":2.446375,"peRate":22.698435,"turnoverRate":0.001798,"increases":39,"decrements":13,"flats":1,"marketCap":3116462076288,"floatMarketCap":2349286177344},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":524.6792,"amplitude":0.013367,"preClose":520.89703,"low":517.7165,"pbRate":"2.446375","latestPrice":524.5661,"volume":250670138,"delay":0,"open":520.9091,"prevYearClose":446.93042,"prevWeekClose":520.897,"prevMonthClose":522.73,"prevQuarterClose":552.537,"fiveDayClose":527.82,"twentyDayClose":537.869,"sixtyDayClose":561.622,"secType":"PLATE","market":"HK","turnoverRate":0.001798,"peRate":22.698435,"marketCap":3116462076288,"floatMarketCap":2349286177344,"timestamp":1762747199373,"nameCN":"高瓴概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":39,"down":13,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2582811076","title":"信达生物与圣因生物共同宣布IBI3016(AGT siRNA)I期临床研究结果于2025年AHA大会现场报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2582811076","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582811076?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 08:00","pubTimestamp":1762732800,"startTime":"0","endTime":"0","summary":"在北京大学第三医院研究中心、信达生物和圣因生物三方的通力协作与专业投入下,IBI3016 I期得到了良好的阶段性成果并在国际大会中汇报。IBI3016基于圣因生物专有小核酸药物开发平台具有自主知识产权的GalNAc肝靶向递送技术开发,通过RNAi机制抑制AGT的合成。临床前试验数据显示,IBI3016可抑制AGT在肝脏中的合成,从而可能导致AGT蛋白的持久减少,进一步导致Ang II 的减少,最终起到舒张血管、降低血压的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4818720_ZH18720_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU2097828631.EUR","01801","LU0455707207.USD","BK1589","BK1583","LU2097828557.USD","LU2097828805.USD","HK0000165453.HKD","LU0502904849.HKD","AGT","IVBIY","LU2242644610.SGD","BK1161","BK4139","LU2488822045.USD","LU2328871848.SGD","LU2097828714.EUR","LU1969619763.USD","LU2097828474.EUR"],"gpt_icon":0},{"id":"2582814573","title":"医保卡变“购物卡”?央视曝光“套”刷医保卡黑链条","url":"https://stock-news.laohu8.com/highlight/detail?id=2582814573","media":"央视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582814573?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 07:59","pubTimestamp":1762732740,"startTime":"0","endTime":"0","summary":" 今年早些时候,全国多地医保局陆续发布了“禁止将医保卡变为‘购物卡’”的预警提示。提示中明确提到,部分企业为了使商品可以刷医保个人账户进行支付,将牙刷、面膜等非医疗作用的产品申请为医疗器械,以此规避生活用品类不能刷医保卡的问题。这种行为违反了医保个人账户资金的正当使用规定,医保个人账户资金专款专用,仅限医疗相关支出,骗保行为将面临法律惩戒。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-11-10/doc-infwwmfe3090868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1583","BK1574","BK1100","09997","BK1222","09996"],"gpt_icon":0},{"id":"2582819964","title":"深耕骨科 50 年,CeramTec凭什么成为强生、威高等巨头的依赖?","url":"https://stock-news.laohu8.com/highlight/detail?id=2582819964","media":"医工加油站","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582819964?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 01:38","pubTimestamp":1762709905,"startTime":"0","endTime":"0","summary":"全球每两台髋关节置换手术中,就有一台使用CeramTec的陶瓷部件。中国所有的人工关节制造企业,包括爱康医疗、春立医疗、威高骨科等,生产所需的高端陶瓷零件100%依赖CeramTec。作为人工髋关节置换术陶瓷部件的主要供应商,它积累了 50 余年的专业经验,截至目前,该系列产品已在全球范围内成功植入超1800 万次,拯救了无数受关节疼痛困扰的患者。03市场高度依赖在陶瓷人工关节领域,CeramTec的垄断力简直 “令人咋舌”!","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110014001a6ed6b36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110014001a6ed6b36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01789","09997","BK1585","BK1617","BK1222","BK1100","BK1583","09996","BK1574"],"gpt_icon":0},{"id":"2582816482","title":"BD神话带不动创新药了?","url":"https://stock-news.laohu8.com/highlight/detail?id=2582816482","media":"药闻社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582816482?lang=zh_cn&edition=fundamental","pubTime":"2025-11-09 23:12","pubTimestamp":1762701136,"startTime":"0","endTime":"0","summary":"总额高达114亿美元,刷新中国药企BD交易金额记录。MNC倾向靠“堆量”逻辑大批购买中国早期资产,但二级市场流通的钱一共就那么多,投资者在大量雷同交易中渐渐会出现选择犹豫或“祛魅”心态,最终出现“BD带不动创新药”的现象;裂痕已经初见端倪。而目前中国创新药企业交易的BD管线,大部分都属于后面一种情况。2019年,武田以约620亿美元收购Shire,使其背负了巨额债务。和传统BD相比,Co-Co中里程碑付款占总款比例较高,这也","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251109231734a494f4b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251109231734a494f4b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1583","BK1574","03692","BK1589","BK1161","06978"],"gpt_icon":0},{"id":"2582389201","title":"国科恒泰:医疗器械第三方制造相关业务尚处于前期研究探索阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2582389201","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582389201?lang=zh_cn&edition=fundamental","pubTime":"2025-11-09 21:56","pubTimestamp":1762696560,"startTime":"0","endTime":"0","summary":"国科恒泰近日在机构调研时表示,目前公司医疗器械第三方制造相关业务尚处于前期研究探索阶段,对公司短期经营业绩不构成影响。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2025-11-09/doc-infwvitk9979673.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-11-09/doc-infwvitk9979673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0250","09996","BK1222","301370","159883","BK1574","09997","BK1100","BK1583"],"gpt_icon":0},{"id":"2582989207","title":"【国投证券 | 医药】医药板块25Q3季报总结:创新出海率先回暖,其他细分静待改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2582989207","media":"国投证券医药研究","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582989207?lang=zh_cn&edition=fundamental","pubTime":"2025-11-09 21:53","pubTimestamp":1762696384,"startTime":"0","endTime":"0","summary":"2025Q3单季度化学原料药板块营收同比下降3.25%,归母净利润同比下降32.42%,扣非净利润同比下降37.82%。医疗器械:2025Q3 单季度来看,医疗器械板块整体营收同比增长1.38%,归母净利润同比减少14.31%,扣非净利润同比减少14.29%,毛利率为54.32%,扣非净利率为15.55%。在国投证券医药分类下,除去医药主业不突出的转型类公司。其中,医药行业的归母净利润同比下滑1.59%,位居28个基期非亏损的申万一级行业中的第18位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251109220019a494d616&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251109220019a494d616&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1969619763.USD","LU2328871848.SGD","LU2097828631.EUR","BK1589","09939","01801","LU0502904849.HKD","LU2097828474.EUR","LU2097828805.USD","BK1515","LU2488822045.USD","BK1574","BK1161","HK0000165453.HKD","LU2097828714.EUR","LU0455707207.USD","LU2097828557.USD","BK1583","LU2242644610.SGD"],"gpt_icon":0},{"id":"2582065818","title":"【国投证券 | 医药】新药周观点:25Q3泽布替尼美国市场份额首次超越伊布替尼","url":"https://stock-news.laohu8.com/highlight/detail?id=2582065818","media":"国投证券医药研究","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582065818?lang=zh_cn&edition=fundamental","pubTime":"2025-11-09 21:53","pubTimestamp":1762696384,"startTime":"0","endTime":"0","summary":"泽布替尼2025年前三季度全球整体销售额达27.42亿美元。市场份额方面,全球来市场看25Q3泽布替尼份额达28.9%,全球市场处于强生/艾伯维伊布替尼后第二位;美国市场来看份额达33.8%,首次超越伊布替尼在美国市场处于第一位;从放量趋势看泽布替尼市场份额仍在不断提升中。结果显示,在研口服司美格鲁肽25 mg在多种体重减轻幅度类别中,均与血糖控制及心血管风险因素的显著改善相关。根据协议条款圣因生物将获得包括首付款和股权投资的近期付款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251109215921a6ed1c13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251109215921a6ed1c13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","LU1719994722.HKD","LU1969619763.USD","LU1303224171.USD","LU0307460666.USD","LU1251922891.USD","BK1583","LU2328871848.SGD","BK1500","BK1574","BK1588","BK1161","LU0588546209.SGD","09939","LU1770034418.SGD","06160"],"gpt_icon":0},{"id":"2582014892","title":"全国社保基金理事会原副理事长王忠民:低息差时代的资产管理核心就是向风险要收益、向风险要资产配置","url":"https://stock-news.laohu8.com/highlight/detail?id=2582014892","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582014892?lang=zh_cn&edition=fundamental","pubTime":"2025-11-09 21:30","pubTimestamp":1762695000,"startTime":"0","endTime":"0","summary":"在本次金融发展年会上,全国社保基金理事会原副理事长王忠民发表了题为《低息差时代的金融强国之路》的主题演讲。王忠民表示,在当前低利率环境下,无风险资产的利差收窄,吸引力下降。王忠民表示,新时代的风险逻辑包含两个核心层面,即风险管理和风险投资,二者共同构成资管行业的新的底层逻辑。王忠民表示,未来资产管理的核心能力将是“风险智慧”,即精准识别风险、有效管理风险、勇敢承担风险。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2025-11-09/doc-infwvits3669587.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-11-09/doc-infwvits3669587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09983","BK1583","BK1258","BK1229","BK1542"],"gpt_icon":0},{"id":"2582891775","title":"美团在深圳启动“迎赛事•团行动” 助力城市文商旅体融合发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2582891775","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582891775?lang=zh_cn&edition=fundamental","pubTime":"2025-11-09 19:06","pubTimestamp":1762686360,"startTime":"0","endTime":"0","summary":"转自:经济日报11月7日,美团在深圳举办“迎赛事·团行动”主题活动,并发布“骑手服务接力行动”“速度与温度骑手关怀计划”“消费生态助力计划”等一系列专项举措,旨在通过平台技术、生态与服务优势,践行企业社会责任,助力城市文商旅体融合发展。美团“小黄灯”消费补贴计划启动仪式。佳音摄据介绍,在十五运会期间,美团“骑手服务接力行动”将为游客、市民提供良好的志愿帮助服务,营造良好的赛事氛围。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-11-09/doc-infwvcmr2355700.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0588545730.USD","LU0143863784.USD","LU0348827113.USD","BK1583","LU0359202008.SGD","LU0588545904.SGD","LU1048596156.SGD","LU0228659784.USD","03690","LU0819123356.HKD","LU2152927971.USD","LU1688375341.USD","LU1152091754.HKD","LU0531971595.HKD","LU1242518857.USD","LU0880133367.SGD","LU0251144936.SGD","MPNGY","BK1233","LU1880383366.USD","BK4209","LU0541502299.USD","LU1102505762.USD","LU1226287529.USD","LU1323998911.USD","LU0348816934.USD","LU1813983027.USD","LU0417516902.SGD","HMTD.SI","LU0143863198.USD","LU0345776255.USD","LU0918141887.USD","BK4122","IE0032431581.USD","METmain","LU1868837565.USD","IE00B543WZ88.USD","LU0431992006.USD","BK1604","LU0348805143.USD","LU0594300179.USD","LU1831875114.USD","LU0054237671.USD","LU0823039010.USD","LU2257852520.SGD","SG9999001689.USD","LU0345775950.USD","LU0594300419.USD","LU1481107354.HKD","LU0106252389.USD"],"gpt_icon":1},{"id":"2582498891","title":"兴证策略:“以我为主” 两条思路布局明年景气预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2582498891","media":"兴业证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582498891?lang=zh_cn&edition=fundamental","pubTime":"2025-11-09 18:07","pubTimestamp":1762682820,"startTime":"0","endTime":"0","summary":"随着海外流动性担忧缓解、美联储降息预期重新校准、11月19日英伟达业绩发布提供新催化后,局部明年景气预期或将更加顺畅。A股在平稳的经济和政策预期支撑下或仍将具备韧性,继续“”以我为主,两条思路布局明年景气预期。风险提示经济数据波动,政策宽松低于预期,美联储降息不及预期等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251109181110a6ecc302&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251109181110a6ecc302&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1046422090.SGD","LU2125910500.SGD","02359","BK1583","LU0708995583.HKD","BK1141","01880","LU2045819591.USD","BK1576","LU0052750758.USD","LU0320764599.SGD","LU2242644610.SGD"],"gpt_icon":0},{"id":"2582922678","title":"借力进博舞台,联众医疗获SGS数据资产管理认证,推动医疗行业标准化破局","url":"https://stock-news.laohu8.com/highlight/detail?id=2582922678","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582922678?lang=zh_cn&edition=fundamental","pubTime":"2025-11-09 17:06","pubTimestamp":1762679178,"startTime":"0","endTime":"0","summary":"在第八届中国国际进口博览会期间,国际公认的测试、检验和认证机构SGS为杭州联众医疗科技股份有限公司颁发数据资产管理体系认证证书。这标志着联众医疗成为国内医疗行业首批通过数据资产管理体系认证的企业之一,不仅证明其数据管理能力达到国际标准,更推动了医疗行业数据资产管理的规范化发展。SGS在进博会现场为联众医疗颁发数据资产管理体系认证证书","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110917074494f9056c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110917074494f9056c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1229","BK1583","BK1258","06899","BK1104","BK1531","BK1542","09983"],"gpt_icon":0},{"id":"2582816877","title":"泰它西普治疗IGA肾病的优异疗效和安全性早已显露在销售收入里","url":"https://stock-news.laohu8.com/highlight/detail?id=2582816877","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582816877?lang=zh_cn&edition=fundamental","pubTime":"2025-11-09 17:03","pubTimestamp":1762678980,"startTime":"0","endTime":"0","summary":"数据显示泰它西普治疗IGA肾病不仅可以显著降低蛋白尿、同时维持肾功能稳定,展示出优异疗效和安全性。今年一到三季度,泰它西普治疗肾病的销售收入已占泰它西普全部销售收入的三成,占比排第二位,仅次于系统性红斑狼疮。我们完全有理由相信,随着这次ASN会议上泰它西普治疗IGA肾病三期临床试验的优异疗效和安全性数据公布,以及明年该适应症获批上市并纳入医保,未来泰它西普治疗IGA肾病的销售收入将迎来井喷式增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251109181802a4947b58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251109181802a4947b58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09995","LU1969619763.USD","BK1161","LU2328871848.SGD","BK1583","BK1574"],"gpt_icon":0},{"id":"2582895896","title":"快递迎来“小时达”时代!你的“身边仓”接单了","url":"https://stock-news.laohu8.com/highlight/detail?id=2582895896","media":"北京青年报官网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582895896?lang=zh_cn&edition=fundamental","pubTime":"2025-11-09 14:29","pubTimestamp":1762669755,"startTime":"0","endTime":"0","summary":"进入11月,我国快递业迎来业务旺季,日均快递业务量已突破6亿件。依托无人机突破地面交通时空限制,算法持续优化每一条配送路径等,重点城市“当日达”“次日达”服务广泛覆盖,“小时达”成为常态,“万物到家”已经真正融入日常。新消费模式“即时零售”正在改变你我的生活。从“等快递”到“小时达”,即时零售让“即买即用”成为日常。“当日达”“小时达”的短链路又是怎么实现的?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251109143306a4941eea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251109143306a4941eea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0181495838.USD","LU0106252389.USD","BK1591","HMTD.SI","LU0261950983.USD","03690","LU0348827113.USD","LU2097828714.EUR","IE0008369823.USD","IE00B0JY6N72.USD","LU0049853897.USD","LU0143863784.USD","LU2242644610.SGD","IE00B3M56506.USD","LU0043850808.USD","LU0165289439.USD","LU2152927971.USD","SG9999002463.SGD","LU0633140560.USD","LU0823426480.USD","LU0211977185.USD","LU0577902371.SGD","LU0633140727.USD","LU2097828631.EUR","LU0244354667.USD","LU1282648689.USD","02618","LU0251144936.SGD","MPNGY","LU0823040885.USD","LU0067412154.USD","LU0164865239.USD","LU0417516738.SGD","LU0541502299.USD","LU1242518931.SGD","LU1868837565.USD","LU0577902538.SGD","LU0210526637.USD","BK1604","LU0456827905.SGD","LU0359201612.USD","LU0143863198.USD","METmain","LU2097828805.USD","IE0032431581.USD","LU1152091754.HKD","LU0072913022.USD","BK1583","IE00B031HY20.USD","LU2097828557.USD","LU0499858602.USD"],"gpt_icon":1},{"id":"2582895868","title":"只拼价格不够!GLP-1减肥针“双十一”爆发式增长,京东健康在下一盘生态大棋","url":"https://stock-news.laohu8.com/highlight/detail?id=2582895868","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582895868?lang=zh_cn&edition=fundamental","pubTime":"2025-11-09 12:45","pubTimestamp":1762663535,"startTime":"0","endTime":"0","summary":"上亿减重用户涌入、超六成人群常态化用药、购药频次5年内复合增长超过20%……当“体重管理”成为全民健康议题,今年双十一的消费市场,GLP-1类“减肥针”毫无悬念地接过增长接力棒,成为继美妆、家电之后的现象级爆品。而这股热潮早已埋下伏笔——在几个月前的“618”中,京东健康平台的GLP-1类用药销量同比增长超3倍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://biz.eastmoney.com/a/202511093558974495.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://biz.eastmoney.com/a/202511093558974495.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1247","BK1571","BK1583","86618","SGXZ86797644.SGD","BK4590","BK1515","BK4144","06618","GLP","BK1591","LU0456827905.SGD","BK1615","BK1142","SGXZ62798434.SGD","LU0051755006.USD","BK1589"],"gpt_icon":0},{"id":"2582898256","title":"和铂医药-B于11月7日斥资497.15万港元回购40万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2582898256","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582898256?lang=zh_cn&edition=fundamental","pubTime":"2025-11-09 11:28","pubTimestamp":1762658880,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 和铂医药-B(02142)发布公告,于2025年11月7日该公司斥资497.15万港元回购40万股,回购价格为每股11.98-12.70港元。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-11-09/doc-infwunqa4082461.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1583","BK1161","BK1574","02142"],"gpt_icon":0},{"id":"2582989848","title":"归创通桥于11月7日斥资117.2万港元回购5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2582989848","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582989848?lang=zh_cn&edition=fundamental","pubTime":"2025-11-09 11:16","pubTimestamp":1762658160,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 归创通桥(02190)发布公告,于2025年11月7日斥资117.2万港元回购5万股。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-11-09/doc-infwunpx2661004.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1583","BK1587","BK1574","02190","BK1100"],"gpt_icon":0},{"id":"2582867556","title":"小小儿童餐 吃出“大蛋糕” 万亿市场规模引来众多知名餐饮企业布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2582867556","media":"深圳商报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582867556?lang=zh_cn&edition=fundamental","pubTime":"2025-11-09 07:27","pubTimestamp":1762644445,"startTime":"0","endTime":"0","summary":"根据《2023儿童餐食行业研究报告》,儿童餐食市场已经突破万亿元规模。7月21日,儿童旅客展示上海铁路局在今年暑运期间首次推出的儿童餐。除了海底捞,西贝、九毛九等连锁餐饮品牌也是儿童餐市场的重要参与者。昔日安静的儿童餐市场,正成为餐饮业争夺的黄金赛道。2022年,西贝将“儿童餐”升级为“专业儿童餐”。在国内儿童餐市场,西贝长期占据领跑者地位。业内人士指出,推进儿童餐市场规范发展,需从标准制定入手。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251109072733a6ebc890&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251109072733a6ebc890&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1591","09922","06862","BK1233","LU2488822045.USD","BK1604","BK1589","BK1583","IE0034224299.USD"],"gpt_icon":0},{"id":"2582892075","title":"医药生物行业周报:流感高发 关注相关投资机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2582892075","media":"开源证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582892075?lang=zh_cn&edition=fundamental","pubTime":"2025-11-09 00:00","pubTimestamp":1762617600,"startTime":"0","endTime":"0","summary":"流感“防-诊-治”意义凸显,疫苗、感护、检测及药物产业链有望受益流感防控诊疗的战略意义凸显,疫苗、感护、检测及药物产业链有望迎来结构性机遇。受流感高发期催化,本周市场相关板块关注度显著提升,部分标的涨幅居前。上述公司均位居各自板块涨幅榜前五,我们认为其行情主要受到流感季节性高发带来的主题性投资机会驱动。本周医药生物下跌2.4%,跑输沪深300 指数3.22pct,在31 个子行业中排名第29 位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251109211631975e2f60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251109211631975e2f60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","LU2097828474.EUR","LU1969619763.USD","LU2097828631.EUR","LU2097828714.EUR","LU0455707207.USD","BK1589","LU2242644610.SGD","LU2328871848.SGD","LU2097828557.USD","LU2097828805.USD","HK0000165453.HKD","BK1161","01801","LU2488822045.USD","LU0502904849.HKD"],"gpt_icon":0},{"id":"2581863196","title":"聚焦进博会|进口人工心脏、三尖瓣加速入华 心血管医疗器械赛道活跃","url":"https://stock-news.laohu8.com/highlight/detail?id=2581863196","media":"第一财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581863196?lang=zh_cn&edition=fundamental","pubTime":"2025-11-08 22:28","pubTimestamp":1762612126,"startTime":"0","endTime":"0","summary":"在第八届进博会上,心血管医疗器械赛道仍是各大跨国医疗厂商竞逐的赛道。近几年来,强生公司通过一系列收购加强了心血管领域的布局,这也让心血管领域的巨头之争加剧。第一财经记者在进博会上了解到,强生公司的一款介入式人工心脏设备Impella目前已进入中国产品注册的最后冲刺阶段,预计于今年年底或明年年初正式在中国国内获批上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511083558916629.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511083558916629.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09996","BK1574","BK1583","BK1222","09997","BK1100"],"gpt_icon":0},{"id":"2581686874","title":"(第八届进博会)民企话进博会:架起全球商品与中国消费者“双向奔赴”通道","url":"https://stock-news.laohu8.com/highlight/detail?id=2581686874","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581686874?lang=zh_cn&edition=fundamental","pubTime":"2025-11-08 21:00","pubTimestamp":1762606827,"startTime":"0","endTime":"0","summary":"中新社上海11月8日电(陶思阅)第八届中国国际进口博览会(简称“进博会”)正在举办,多家中国民营企业通过提供消费选择、购买平台、支付服务、物流服务等方式,在全球商品与中国消费者之间架起桥梁。向他人推荐好物的小红书“种草”帖,让全球商品呈现在中国消费者眼前,也使全球企业快速洞察中国本土消费需求。数据显示,在小红书上,每月超1.7亿用户寻求购买建议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511083558908675.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511083558908675.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1591","SGXZ62798434.SGD","SGXZ86797644.SGD","BK1589","BK1142","LU0456827905.SGD","BK1615","86618","BK1515","LU0051755006.USD","06618","BK1247","BK1571","BK1583"],"gpt_icon":0}],"pageSize":20,"totalPage":43,"pageCount":1,"totalSize":843,"code":"91000000","status":"200"}]}}